Skip to Content

Hydroxychloroquine Sulfate Tablets

Last Updated: September 14, 2015
Status: Resolved

Products Affected - Description

Hydroxychloroquine sulfate tablets, Ranbaxy
200 mg, 100 count (NDC 63304-0296-01)
200 mg, 500 count (NDC 63304-0296-05)

Reason for the Shortage

  • Concordia acquired Plaquenil tablets from Covis in April 2015.
  • Ranbaxy has hydroxychloroquine on shortage due to a regulatory issue.
  • Sandoz states the hydroxychloroquine shortage was due to increased demand.
  • Zydus could not provide a reason for hydroxychloroquine shortage.
  • West-Ward discontinued hydroxychloroquine tablets in September 2014.

Available Products

Hydroxychloroquine sulfate tablet, Mylan
200 mg, 100 count (NDC 00378-0373-01)

 
Hydroxychloroquine sulfate tablet, Sandoz
200 mg, 100 count (NDC 00781-1407-97)
200 mg, 500 count (NDC 00781-1407-52)
 
Hydroxychloroquine sulfate tablet, Zydus
200 mg, 100 count (NDC 68382-0096-01)
 
Plaquenil tablet, Concordia
200 mg, 100 count (NDC 24987-0562-10)

Estimated Resupply Dates

  • Ranbaxy has product on long-term back order and the company cannot estimate a release date.
  • All other suppliers have product available.

Related Shortages

Updated

September 14, July 22, May 6 and 18, May 6, April 6, March 18 and 23, March 18, January 14, 2015; December 5, October 10, September 5 and 18, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide